Andreu Llorente

935 total citations
20 papers, 491 citations indexed

About

Andreu Llorente is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Andreu Llorente has authored 20 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Andreu Llorente's work include Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Andreu Llorente is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Andreu Llorente collaborates with scholars based in Spain and Nigeria. Andreu Llorente's co-authors include Joan Cid, Graciano García‐Pardo, Rafáel Sánchez, Lourdes Escoda, Josep Nomdedéu, Josep‐María Ribera, Jordi Esteve, Mar Tormo, Salut Brunet and Maria-Elena Cabezudo and has published in prestigious journals such as Blood, Cancer and Thrombosis and Haemostasis.

In The Last Decade

Andreu Llorente

20 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreu Llorente Spain 11 170 163 135 121 85 20 491
P.C. Huijgens Netherlands 15 97 0.6× 198 1.2× 140 1.0× 61 0.5× 162 1.9× 32 535
Hyun-Sook Chi South Korea 13 58 0.3× 225 1.4× 79 0.6× 99 0.8× 101 1.2× 33 503
Prassede Salutari Italy 13 94 0.6× 220 1.3× 80 0.6× 61 0.5× 132 1.6× 40 438
Colombe Saillard France 13 143 0.8× 274 1.7× 91 0.7× 76 0.6× 176 2.1× 34 515
Canan Vergin Türkiye 13 79 0.5× 96 0.6× 104 0.8× 109 0.9× 46 0.5× 47 400
Edythe A. Albano United States 13 230 1.4× 190 1.2× 128 0.9× 74 0.6× 202 2.4× 24 714
Lalita Norasetthada Thailand 11 105 0.6× 240 1.5× 110 0.8× 64 0.5× 137 1.6× 105 595
E. Koivunen Finland 14 58 0.3× 252 1.5× 89 0.7× 102 0.8× 129 1.5× 24 451
C. N. Nair India 14 92 0.5× 87 0.5× 76 0.6× 86 0.7× 120 1.4× 41 493
Alex Ganetsky United States 13 52 0.3× 154 0.9× 109 0.8× 163 1.3× 177 2.1× 35 504

Countries citing papers authored by Andreu Llorente

Since Specialization
Citations

This map shows the geographic impact of Andreu Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreu Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreu Llorente more than expected).

Fields of papers citing papers by Andreu Llorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreu Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreu Llorente. The network helps show where Andreu Llorente may publish in the future.

Co-authorship network of co-authors of Andreu Llorente

This figure shows the co-authorship network connecting the top 25 collaborators of Andreu Llorente. A scholar is included among the top collaborators of Andreu Llorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreu Llorente. Andreu Llorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribera, Josep‐María, Olga García, Carlos Grande, et al.. (2013). Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status. Cancer. 119(9). 1660–1668. 46 indexed citations
2.
Nomdedéu, Josep, Montserrat Hoyos, Elena Bussaglia, et al.. (2013). Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML. Leukemia. 27(11). 2157–2164. 57 indexed citations
3.
Hoyos, Montserrat, Josep Nomdedéu, Jordi Esteve, et al.. (2013). Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease. European Journal Of Haematology. 91(3). 209–218. 34 indexed citations
4.
Llorente, Andreu, Ignacio Valero, Inmaculada Heras, et al.. (2011). Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enfermedades Infecciosas y Microbiología Clínica. 29(4). 263–268. 8 indexed citations
5.
Cid, Joan, et al.. (2011). Neutrophil CD64: diagnostic accuracy and prognostic value in patients presenting to the emergency department. European Journal of Clinical Microbiology & Infectious Diseases. 30(7). 845–852. 24 indexed citations
6.
Cid, Joan, et al.. (2010). Neutrophil CD64 expression as marker of bacterial infection: A systematic review and meta-analysis. Journal of Infection. 60(5). 313–319. 124 indexed citations
7.
8.
Granada, Isabel, Salut Brunet, Montserrat Hoyos, et al.. (2009). Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.. Blood. 114(22). 1003–1003. 3 indexed citations
9.
10.
Monzó, Mariano, Salut Brunet, Álvaro Urbano-Ispizúa, et al.. (2006). Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood. 107(12). 4871–4879. 59 indexed citations
11.
Llorente, Andreu, et al.. (2005). Postpartum ovarian vein thrombosis. Thrombosis and Haemostasis. 93(5). 1004–1005. 40 indexed citations
12.
Ortı́n, Xavier, Lourdes Escoda, Andreu Llorente, et al.. (2003). Cunninghamella Bertholletiae Infection (Mucormycosis) in a Patient with Acute T-cell Lymphoblastic Leukemia. Leukemia & lymphoma. 45(3). 617–620. 11 indexed citations
13.
Ortı́n, Xavier, et al.. (2002). Cerebrovascular nodules in a patient with leukostasis. Transfusion. 42(8). 965–965. 2 indexed citations
14.
Lasa, Adriana, Josep Nomdedéu, Maria J. Carnicer, Andreu Llorente, & Jorge Sierra. (2002). ETO sequence may be dispensable in some AML1-ETO leukemias. Blood. 100(12). 4243–4244. 4 indexed citations
15.
Nomdedéu, Josep, et al.. (1999). Enhanced myeloid specificity of CD 117 compared with CD13 and CD33. Leukemia Research. 23(4). 341–347. 19 indexed citations
16.
Montserrat, E, J Garcı́a-Conde, Núria Viñolas, et al.. (1996). CHOP vs. ProMACE‐CytaBOM in the treatment of aggressive non‐Hodgkin's lymphomas: long‐term results of a multicenter randomized trial. European Journal Of Haematology. 57(5). 377–383. 28 indexed citations
17.
Mateu, J., et al.. (1993). [The extravasation of cytostatic drugs: its diagnosis, evolution and treatment].. PubMed. 101(3). 105–9. 5 indexed citations
18.
Llorente, Andreu, et al.. (1988). [Leukocytoclastic vasculitis and multiple myeloma. Presentation of 2 cases].. PubMed. 91(11). 420–3. 2 indexed citations
19.
Costa, B, et al.. (1986). [Meningeal myelomatosis. Presentation of a case and review of the literature].. PubMed. 86(20). 848–50. 1 indexed citations
20.
Llorente, Andreu, et al.. (1982). [Epidemiological study of hepatitis A using the measurement of anti-VHA antibody].. PubMed. 165(1). 11–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.C. Huijgens Breakdown of academic impact, for papers by Hyun-Sook Chi Breakdown of academic impact, for papers by Prassede Salutari Breakdown of academic impact, for papers by Colombe Saillard Breakdown of academic impact, for papers by Canan Vergin Breakdown of academic impact, for papers by Edythe A. Albano Breakdown of academic impact, for papers by Lalita Norasetthada Breakdown of academic impact, for papers by E. Koivunen Breakdown of academic impact, for papers by C. N. Nair Breakdown of academic impact, for papers by Alex Ganetsky
Rankless by CCL
2026